NBIX : Neurocrine Biosciences stock forecast, predictions, and share price target for 2021, 2022 (1 year) to 2025, 2026 (5 year) to 2030, and 2031 (10 year)

The 6 Wall Street analysts offering Neurocrine Biosciences stock forecast in the last 6 months have average price target of $119.17 with a high forecast of $163.0 and a low forecast of $90.0. The average Neurocrine Biosciences stock forecast represents a 23.48% increase from the last price of $96.51. From AI system, total return is 2053.81% from 1638 forecasts. For Neurocrine Biosciences stock forecast 2021, 8 predictions are offered for each month of 2021 with average Neurocrine Biosciences stock forecast of $83.83, a high forecast of $93.89, and a low forecast of $76.26. The average Neurocrine Biosciences stock forecast 2021 represents a -13.14% decrease from the last price of $96.51. For Neurocrine Biosciences stock forecast 2022, 12 predictions are offered for each month of 2022 with average Neurocrine Biosciences stock forecast of $74.14, a high forecast of $83.63, and a low forecast of $50.94. The average Neurocrine Biosciences stock forecast 2022 represents a -23.18% decrease from the last price of $96.51. For Neurocrine Biosciences stock forecast 2025, 12 predictions are offered for each month of 2025 with average Neurocrine Biosciences stock forecast of $26.25, a high forecast of $27.84, and a low forecast of $24.52. The average Neurocrine Biosciences stock forecast 2025 represents a -72.8% decrease from the last price of $96.51. For Neurocrine Biosciences stock forecast 2026 (5 year), 12 predictions are offered for each month of 2026 with average Neurocrine Biosciences stock forecast of $21.33, a high forecast of $23.98, and a low forecast of $19.86. The average Neurocrine Biosciences stock forecast 2026 represents a -77.9% decrease from the last price of $96.51. For Neurocrine Biosciences stock forecast 2030, 12 predictions are offered for each month of 2030 with average Neurocrine Biosciences stock forecast of $20.01, a high forecast of $22.91, and a low forecast of $17.86. The average Neurocrine Biosciences stock forecast 2030 represents a -79.26% decrease from the last price of $96.51. For Neurocrine Biosciences stock forecast 2031 (10 year), 4 predictions are offered for each month of 2031 with average Neurocrine Biosciences stock forecast of $11.34, a high forecast of $15.54, and a low forecast of $7.93. The average Neurocrine Biosciences stock forecast 2031 represents a -88.25% decrease from the last price of $96.51. Please, see more forecasts below.